Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320463
Status:
COMPLETED
Last Update Posted:
2016-10-12
First Post:
2006-02-21
Brief Title:
Compare Immunogenicity Safety of 2 Formulations of GSK Biologicals DTPa-HBV-IPVHib Vaccine Given in Healthy Infants
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-21
First Submit QC Date:
April 28 2006
Study First Post Date:
2006-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-11
Last Update Post Date:
2016-10-12
Last Update Post Date Type:
ESTIMATED